Mind Medicine Analyst Ratings

BenzingaDec 17 11:09 ET · Ratings

Wolfe's Top 12 Shorted Stocks: FSLR, BE, WBA, and More

Seeking AlphaDec 16 15:45 ET

Summit Therapeutics Shares Are Trading Higher. The Stock May Be Moving in Sympathy With Neurocrine Biosciences Which Received FDA Approval for CRESNESSITY.

BenzingaDec 16 15:23 ET

MindMed Doses First Patient in Phase 3 Trial of LSD Trial for Anxiety

Seeking AlphaDec 16 10:12 ET

Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential

BenzingaDec 16 09:10 ET

Wedbush Reiterates Outperform on Neurocrine Biosciences, Maintains $148 Price Target

BenzingaDec 16 08:25 ET · Ratings